The evaluation and management of thyrotoxicosis

Current Paediatrics

Volumn 14, Issue 5, 2004, Pages 430-437

  Johnstone, H C ^a   Dharmaraj, P ^a   Cheetham, T D ^a  

^a ROYAL VICTORIA INFIRMARY   (United Kingdom)

Author keywords

Anti thyroid drugs; Graves' disease; Radio iodine; Thyrotoxicosis

Indexed keywords

ANTITHYROID AGENT; ATENOLOL; AUTOANTIBODY; CARBIMAZOLE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; FOLLITROPIN; GUANINE NUCLEOTIDE BINDING PROTEIN; IODINE 131; IOPODATE SODIUM; LUGOL; LUTEINIZING HORMONE; PROPRANOLOL; PROPYLTHIOURACIL; RADIOACTIVE IODINE; TECHNETIUM 99M; THYROGLOBULIN; THYROTROPIN;

AGRANULOCYTOSIS; ALBRIGHT SYNDROME; ARTHRALGIA; AUTOIMMUNE DISEASE; CELL MEMBRANE; CHROMOSOME 6P; CONGENITAL MALFORMATION; DOSE RESPONSE; GRAVES DISEASE; HASHIMOTO DISEASE; HEPATITIS; HORMONE SUBSTITUTION; HUMAN; HYPOPARATHYROIDISM; IMAGING; IMMUNOLOGICAL TECHNIQUE; INCIDENCE; INFERTILITY; PATHOLOGICAL ANATOMY; PATHOPHYSIOLOGY; PEROPERATIVE COMPLICATION; POSTOPERATIVE COMPLICATION; RASH; RECURRENT LARYNGEAL NERVE PALSY; REVIEW; SCAR FORMATION; SCINTISCANNING; SIDE EFFECT; SUBTOTAL THYROIDECTOMY; SYMPTOMATOLOGY; THYROID CRISIS; THYROID GLAND; THYROID HORMONE SYNTHESIS; THYROID SURGERY; THYROIDECTOMY; THYROTOXICOSIS; URTICARIA;

EID: 4143113587     PISSN: 09575839     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cupe.2004.05.007     Document Type: Article

References (20)

1. Gruters A. Ocular manifestations in children and adolescents with thyrotoxicosis. Exp Clin Endocrinol Diabetes. 107(Suppl 5):1999;S172-S174
2. Wong G.W., Lai J., Cheng P.S. Growth in childhood thyrotoxicosis. Eur J Pediatr. 158(10):1999;776-779
3. Vaidya B., Kendall-Taylor P., Pearce S.H. The genetics of autoimmune thyroid disease. J Clin Endocrinol Metab. 87(12):2002;5385-5397
4. Mastorakos G., Mitsiades N.S., Doufas A.G., Koutras D.A. Hyperthyroidism in McCune-Albright syndrome with a review of thyroid abnormalities sixty years after the first report. Thyroid. 7(3):1997;433-439
5. Lazar L., Kalter-Leibovici O., Pertzelan A., et al. Thyrotoxicosis in prepubertal children compared with pubertal and postpubertal patients. J Clin Endocrinol Metab. 85(10):2000;3678-3682
6. Feldt-Rasmussen U., Schleusener H., Carayon P. Meta-analysis evaluation of the impact of thyrotropin receptor antibodies on long term remission after medical therapy of Graves' disease. J Clin Endocrinol Metab. 78(1):1994;98-102
7. Saleh A., Cohnen M., Furst G., et al. Differential diagnosis of hyperthyroidism. doppler sonographic quantification of thyroid blood flow distinguishes between graves' disease and diffuse toxic goitre Exp Clin Endocrinol Diabetes. 110(1):2002;32-36
8. Perrild H., Gruters-Kieslich A., Feldt-Rasmussen U., et al. Diagnosis and treatment of thyrotoxicosis in childhood. A European questionnaire study. Eur J Endocrinol. 131(5):1994;467-473
9. Weetman A.P. Effect of the anti-thyroid drug methimazole on interleukin-1 and interleukin-2 levels in vitro. Clin Endocrinol. 25(2):1986;133-142
10. Romaldini J.H., Bromberg N., Werner R.S., et al. Comparison of effects of high and low dosage regimens of antithyroid drugs in the management of Graves' hyperthyroidism. J Clin Endocrinol Metab. 57(3):1983;563-570
11. Reinwein D., Benker G., Lazarus J.H., Alexander W.D. A prospective randomized trial of antithyroid drug dose in Graves' disease therapy. European Multicenter Study Group on Antithyroid Drug Treatment. J Clin Endocrinol Metab. 76(6):1993;1516-1521
12. Allannic H., Fauchet R., Orgiazzi J., et al. Antithyroid drugs and Graves' disease. a prospective randomized evaluation of the efficacy of treatment duration J Clin Endocrinol Metab. 70(3):1990;675-679
13. Shulman D.I., Muhar I., Jorgensen E.V., et al. Autoimmune hyperthyroidism in prepubertal children and adolescents. comparison of clinical and biochemical features at diagnosis and responses to medical therapy Thyroid. 7(5):1997;755-760
14. Glaser N.S., Styne D.M. Predictors of early remission of hyperthyroidism in children. J Clin Endocrinol Metab. 82(6):1997;1719-1726
15. Segni M., Gorman C.A. The aftermath of childhood hyperthyroidism. J Pediatr Endocrinol Metab. 14(Suppl 5):2001;1277-1282. discussion 1297-8
16. Cheetham T.D., Wraight P., Hughes I.A., Barnes N.D. Radioiodine treatment of Graves' disease in young people. Horm Res. 49(6):1998;258-262
17. Hall P., Holm L.E., Lundell G., Ruden B.I. Tumors after radiotherapy for thyroid cancer. A case-control study within a cohort of thyroid cancer patients. Acta Oncol. 31(4):1992;403-407
18. Holm L.E., Hall P., Wiklund K., et al. Cancer risk after iodine-131 therapy for hyperthyroidism (see comment). J Natl Cancer Inst. 83(15):1991;1072-1077
19. Ron E., Doody M.M., Becker D.V., et al. Cancer mortality following treatment for adult hyperthyroidism. Cooperative Thyrotoxicosis Therapy Follow-up Study Group. JAMA. 280(4):1998;347-355
20. Nebesio T.D., Siddiqui A.R., Pescovitz O.H., Eugster E.A. Time course to hypothyroidism after fixed-dose radioablation therapy of Graves' disease in children. J Pediatr. 141(1):2002;99-103